Melanoma Prevention: Comparison of Different Screening Methods for the Selection of a High Risk Population

by Nevio Dubbini, Antonella Puddu, Grazia Salimbeni, Stefano Malloggi, Daniele Gandini, Pietro Massei, Giuseppe Ferraùto, Tommaso Rubino, Laura Ricci, Giovanni Menchini, Marco Celli, Maurizia Ghilardi, Roberto Gianfaldoni, Serena Gianfaldoni, Andrea Nannipieri, Antonella Romanini
Published 2021-02-01

Stroke secondary prevention, a non-surgical and non-pharmacological consensus definition: results of a Delphi study

by Maggie Lawrence, Eric Asaba, Elaine Duncan, Marie Elf, Gunilla Eriksson, James Faulkner, Susanne Guidetti, Birgitta Johansson, Christina Kruuse, Danielle Lambrick, Caitlin Longman, Lena von Koch, Xu Wang, Olive Lennon
Published 2019-12-01

Cardiac Prevention and Rehabilitation “3.0”: From acute to chronic phase. Position Paper of the ltalian Association for Cardiovascular Prevention and Rehabilitation (GICR-IACPR)...

by Roberto F.E. Pedretti, Francesco Fattirolli, Raffaele Griffo, Marco Ambrosetti, Elisabetta Angelino, Silvia Brazzo, Ugo Corrà, Nicolò Dasseni, Pompilio Faggiano, Giuseppe Favretto, Oreste Febo, Marina Ferrari, Francesco Giallauria, Cesare Greco, Manuela Iannucci, Maria Teresa La Rovere, Mario Mallardo, Antonio Mazza, Massimo Piepoli, Carmine Riccio, Simonetta Scalvini, Luigi Tavazzi, Pier Luigi Temporelli, Gian Francesco Mureddu
Published 2018-10-01

Third phase of cardiac rehabilitation: a nurse-based “home-control” model

by Sara Albertini, Antonella Ciocca, Cristina Opasich, Gian Domenico Pinna, Franco Cobelli
Published 2015-12-01

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?

by George Galyfos, Argyri Sianou
Published 2017-09-01

Interest in screening examinations among cancer patients

by Humeniuk Ewa, Dąbska Olga, Pawlikowska-Łagód Katarzyna, Goś Anna, Matuska Małgorzata
Published 2017-09-01

FREQUENCY OF OCCURRENCE OF RISK FACTORS AND ADHERENCE TO DRUG THERAPY IN YAKUTS WHO UNDERWENT Q-POSITIVE MYOCARDIAL INFARCTION

by E. S. Kylbanova, E. V. Guryeva, A. V. Pavlova
Published 2018-08-01

Arterial hypertension and stroke: cardiac and neurological aspects of secondary prevention

by L.A. Geraskina
Published 2014-10-01

Comparison of device-based physical activity and sedentary behaviour following percutaneous coronary intervention in a cohort from Sweden and Australia: a harmonised, exploratory s...

by Nicole Freene, Sabina Borg, Margaret McManus, Tarryn Mair, Ren Tan, Rachel Davey, Birgitta Öberg, Maria Bäck
Published 2020-05-01

Antiplatelets in secondary stroke prevention

by Olga eShulga, Natan eBornstein
Published 2011-07-01

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials

by Marit de Jong, H. Bart van der Worp, Yolanda van der Graaf, Frank L. J. Visseren, Jan Westerink
Published 2017-10-01

Lipid clinics are urgently required in the Iranian public health system

by Majid Ghayour-Mobarhan, Seyyed Mohammad Reza Kazemi-Bajestani, Gordon Ferns
Published 2010-01-01

Secondary Prevention of Coronary Heart Disease in Primary Health Care

by Olivera Batić-Mujanović, Muharem Zildžić, Azijada Beganlić
Published 2006-05-01

Secondary Cardiovascular Prevention in the Elderly: beyond clinical aspects

by Pasqualina Calisi, Raffaele Griffo
Published 2016-02-01

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues

by N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan
Published 2019-01-01

Statins in Secondary Prevention of Atrial Fibrillation

by V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin
Published 2016-11-01

A simplified approach to identification of risk status in patients with atherosclerotic cardiovascular disease

by Aparna Sajja, MD, Hsin-Fang Li, Kateri J. Spinelli, Amir Ali, Salim S. Virani, Seth S. Martin, Ty J. Gluckman
Published 2021-09-01

Acute Tubular Injury in a Patient on a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor

by June K. Pickett, MD, Maulin Shah, MD, Michael Gillette, PharmD, Peter Jones, MD, Salim Virani, MD, PhD, Christie Ballantyne, MD, Vijay Nambi, MD, PhD
Published 2020-06-01

Inappropriate ICD Shock as a Result of TASER Discharge

by Chirag R. Barbhaiya, MD, Craig Moskowitz, MD, Harish Duraiswami, CCDS, Lior Jankelson, MD, PhD, Robert J. Knotts, MD, Scott Bernstein, MD, David Park, MD, PhD, Douglas Holmes, MD, Anthony Aizer, MD, MS, Larry A. Chinitz, MD
Published 2020-07-01

Risk Factors for the Recurrence of CVD Incidents in Post-Stroke Patients over a 5-Year Follow-Up Period Based on the ICF Classification

by Mateusz Lucki, Ewa Chlebuś, Agnieszka Wareńczak, Przemysław Lisiński
Published 2021-06-01